Title: 
Official Title: To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.
Number of Sections: 3
Source: versions - Introduced in House
Media Type: text/xml

================================================================================

Section 1:
1.Exclusion of compensation provided to participants in clinical trials 
(a)In generalPart III of subchapter B of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting after section 139I the following new section:  139J.Clinical trial payments (a)In generalGross income shall not include any amount received by an individual as a qualified clinical trial payment. 
(b)Qualified clinical trial payment definedFor purposes of this section, the term qualified clinical trial payment means any amount paid to an individual— (1)as compensation for participation by the individual or a dependent of the individual in an approved clinical trial, or  
(2)to reimburse or pay reasonable and necessary expenses incurred in connection with participation by the individual or a dependent of the individual in an approved clinical trial. (c)Other definitionsFor purposes of this section— 
(1)Approved clinical trialThe term approved clinical trial has the meaning given such term in section 2709(d)(1) of the Public Health Service Act (42 U.S.C. 300gg–8(d)(1)), determined by applying disease or condition for life-threatening disease or condition. (2)DependentThe term dependent has the meaning given such term in section 152. . 
(b)Clerical amendmentThe table of sections for part III of subchapter B of chapter 1 of such Code is amended by inserting after the item relating to section 139I the following new item:   Sec. 139J. Clinical trial payments.. (c)Effective dateThe amendment made by this section shall apply to amounts paid after December 31, 2025.

Section 2:
139J.Clinical trial payments (a)In generalGross income shall not include any amount received by an individual as a qualified clinical trial payment. 
(b)Qualified clinical trial payment definedFor purposes of this section, the term qualified clinical trial payment means any amount paid to an individual— (1)as compensation for participation by the individual or a dependent of the individual in an approved clinical trial, or  
(2)to reimburse or pay reasonable and necessary expenses incurred in connection with participation by the individual or a dependent of the individual in an approved clinical trial. (c)Other definitionsFor purposes of this section— 
(1)Approved clinical trialThe term approved clinical trial has the meaning given such term in section 2709(d)(1) of the Public Health Service Act (42 U.S.C. 300gg–8(d)(1)), determined by applying disease or condition for life-threatening disease or condition. (2)DependentThe term dependent has the meaning given such term in section 152.

Section 3:
2.Clinical trial compensation not taken into account for purposes of determining eligibility for Federal programs or assistance 
(a)In generalNotwithstanding any other provision of law, any amount received by an individual as a qualified clinical trial payment shall not be taken into account as income or resources for purposes of determining the eligibility of such individual (or any other individual) for benefits or assistance (or the amount or extent of benefits or assistance) under any Federal program or under any State or local program financed in whole or in part with Federal funds. (b)Qualified clinical trial paymentFor purposes of subsection (a), the term qualified clinical trial payment has the meaning given such term in section 139J(a) of the Internal Revenue Code of 1986 (as added by section 1 of this Act).


================================================================================

Raw Text:
119 HR 4184 IH: To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.
U.S. House of Representatives
2025-06-26
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



I
119th CONGRESS1st Session
H. R. 4184
IN THE HOUSE OF REPRESENTATIVES

June 26, 2025
Mr. Kelly of Pennsylvania (for himself and Ms. Houlahan) introduced the following bill; which was referred to the Committee on Ways and Means

A BILL
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.

 
1.Exclusion of compensation provided to participants in clinical trials 
(a)In generalPart III of subchapter B of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting after section 139I the following new section:  139J.Clinical trial payments (a)In generalGross income shall not include any amount received by an individual as a qualified clinical trial payment. 
(b)Qualified clinical trial payment definedFor purposes of this section, the term qualified clinical trial payment means any amount paid to an individual— (1)as compensation for participation by the individual or a dependent of the individual in an approved clinical trial, or  
(2)to reimburse or pay reasonable and necessary expenses incurred in connection with participation by the individual or a dependent of the individual in an approved clinical trial. (c)Other definitionsFor purposes of this section— 
(1)Approved clinical trialThe term approved clinical trial has the meaning given such term in section 2709(d)(1) of the Public Health Service Act (42 U.S.C. 300gg–8(d)(1)), determined by applying disease or condition for life-threatening disease or condition. (2)DependentThe term dependent has the meaning given such term in section 152. . 
(b)Clerical amendmentThe table of sections for part III of subchapter B of chapter 1 of such Code is amended by inserting after the item relating to section 139I the following new item:   Sec. 139J. Clinical trial payments.. (c)Effective dateThe amendment made by this section shall apply to amounts paid after December 31, 2025. 
2.Clinical trial compensation not taken into account for purposes of determining eligibility for Federal programs or assistance 
(a)In generalNotwithstanding any other provision of law, any amount received by an individual as a qualified clinical trial payment shall not be taken into account as income or resources for purposes of determining the eligibility of such individual (or any other individual) for benefits or assistance (or the amount or extent of benefits or assistance) under any Federal program or under any State or local program financed in whole or in part with Federal funds. (b)Qualified clinical trial paymentFor purposes of subsection (a), the term qualified clinical trial payment has the meaning given such term in section 139J(a) of the Internal Revenue Code of 1986 (as added by section 1 of this Act).